{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["HIV/AIDS", "Moringa oleifera", "antioxidants", "human HepG2 liver cells", "reactive oxygen species", "tenofovir"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37765399", "DateRevised": {"Year": "2023", "Month": "10", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "09", "Day": "12"}], "Language": ["eng"], "ELocationID": ["3235", "10.3390/plants12183235"], "Journal": {"ISSN": "2223-7747", "JournalIssue": {"Volume": "12", "Issue": "18", "PubDate": {"Year": "2023", "Month": "Sep", "Day": "12"}}, "Title": "Plants (Basel, Switzerland)", "ISOAbbreviation": "Plants (Basel)"}, "ArticleTitle": "The Hepatoprotective Effects of <i>Moringa oleifera</i> against Antiretroviral-Induced Cytotoxicity in HepG<sub>2</sub> Cells: A Review.", "Abstract": {"AbstractText": ["The untreated human immunodeficiency virus (HIV), a lentivirus species that attacks immune cells (CD4+ T cells), causes acquired immunodeficiency syndrome (AIDS). HIV-positive people manage HIV/AIDS by using antiretroviral therapy (ART). The ART treatment regimen contains two nucleoside reverse transcriptase inhibitors (NRTIs) and one non-nucleoside reverse transcriptase inhibitor/integrase strand transfer inhibitor. Tenofovir, an NRTI approved for managing HIV infection, is associated with hepatic steatosis and lactic acidosis, which are linked to mitochondrial toxicity and oxidative stress. Due to side-effects associated with ART, people living with HIV often use medicinal plants or a combination of medicinal plants with ART to promote adherence and diminish the side-effects and cytotoxicity. The <i>Moringa oleifera</i> (MO) tree from the family of Moringaceae is among the medicinal trees studied in managing HIV/AIDS in sub-Saharan Africa. The MO tree extracts have been reported to have inhibitory activity primarily against HIV due to their bioactive compounds. However, there is a scarcity of knowledge about the use of the MO tree amongst HIV/AIDS patients receiving ART in South Africa and its effect on patient compliance and outcomes. Thus, this review aims to outline the impact of MO aqueous leaf extract on oxidative stress and antioxidant responses in human HepG<sub>2</sub> liver cells after exposure to antiretrovirals such as tenofovir. The review will contribute to a comprehensive understanding of the potential protective effect of MO aqueous leaf extract on tenofovir-induced cytotoxicity."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Medical Sciences, School of Biomedical Sciences, Faculty of Health Sciences, University of the Free State, Bloemfontein 9300, South Africa."}], "LastName": "Saki", "ForeName": "Mbasakazi", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Medical Sciences, School of Biomedical Sciences, Faculty of Health Sciences, University of the Free State, Bloemfontein 9300, South Africa."}], "LastName": "De Villiers", "ForeName": "Helena", "Initials": "H"}, {"Identifier": ["0000-0002-8257-8601"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Medical Sciences, School of Biomedical Sciences, Faculty of Health Sciences, University of the Free State, Bloemfontein 9300, South Africa."}], "LastName": "Ntsapi", "ForeName": "Claudia", "Initials": "C"}, {"Identifier": ["0000-0002-6040-3966"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Medical Sciences, School of Biomedical Sciences, Faculty of Health Sciences, University of the Free State, Bloemfontein 9300, South Africa."}], "LastName": "Tiloke", "ForeName": "Charlette", "Initials": "C"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Plants (Basel)", "NlmUniqueID": "101596181", "ISSNLinking": "2223-7747"}, "CoiStatement": "The authors declare that there are no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Pillaye J.N., Marakalala M.J., Khumalo N., Spearman W., Ndlovu H. Mechanistic insights into antiretroviral drug-induced liver injury. Pharmacol. Res. Perspect. 2020;8:e00598. doi: 10.1002/prp2.598.", "ArticleIdList": ["10.1002/prp2.598", "PMC7344109", "32643320"]}, {"Citation": "Eilami O., Nazari A., Dousti M., Sayehmiri F., Ghasemi M. Investigation of HIV/AIDS prevalence and associated risk factors among female sex workers from 2010 to 2017: A meta-analysis study. HIV/AIDS Res. Palliat. Care. 2019;11:105\u2013117. doi: 10.2147/HIV.S196085.", "ArticleIdList": ["10.2147/HIV.S196085", "PMC6529623", "31191036"]}, {"Citation": "Spach D.H. Antiretroviral Medications and Initial Therapy HIV Life Cycle and Antiretroviral Drug Targets. National HIV Curriculum, University of Washington; Seattle, WA, USA: 2020."}, {"Citation": "Waters L., Mehta V., Gogtay J., Boffito M. The Evidence for Using Tenofovir Disoproxil Fumarate Plus Lamivudine as a Nucleoside Analogue Backbone for the Treatment of HIV. J. Virus Erad. 2021;7:100028. doi: 10.1016/j.jve.2021.100028.", "ArticleIdList": ["10.1016/j.jve.2021.100028", "PMC7868802", "33598310"]}, {"Citation": "Dumitrescu T.P., Peddiraju K., Fu C., Bakshi K., Yu S., Zhang Z., Tenorio A.R., Spancake C., Joshi S., Wolstenholme A., et al. Bioequivalence and Food Effect Assessment of 2 Fixed-Dose Combination Formulations of Dolutegravir and Lamivudine. Clin. Pharmacol. Drug Dev. 2020;9:189\u2013202. doi: 10.1002/cpdd.740.", "ArticleIdList": ["10.1002/cpdd.740", "PMC7028125", "31724343"]}, {"Citation": "Umar D., Waziri B., Ndagi U., Mohammed S., Usman N., Abubakar-Muhammad H. Impact of Tenofovir/Lamivudine/Dolutegravir (Tld) on the Health-Related Quality of Life and Clinical Outcomes of HIV/AIDS Patients at a Tertiary Health Facility in Niger State. 2020.  [(accessed on 21 February 2021)]. pp. 1\u201318. Available online:  https://www.researchsquare.com/article/rs-127277/v1."}, {"Citation": "Biswas D., Nandy S., Mukherjee A., Pandey D.K., Dey A. Moringa oleifera Lam. and derived phytochemicals as promising antiviral agents: A review. S. Afr. J. Bot. 2020;129:272\u2013282. doi: 10.1016/j.sajb.2019.07.049.", "ArticleIdList": ["10.1016/j.sajb.2019.07.049"]}, {"Citation": "Salami A.T., Okonkwo C.E., Attah F.A., Olagoke O.C. Bioactive Moringa olifera seed extracts attenuates cholesterol gall stones in hyperglycaemic Swiss mice. Comp. Clin. Pathol. 2021;30:207\u2013216. doi: 10.1007/s00580-021-03206-3.", "ArticleIdList": ["10.1007/s00580-021-03206-3"]}, {"Citation": "Rani N.Z.A., Husain K., Kumolosasi E. Moringa genus: A review of phytochemistry and pharmacology. Front. Pharmacol. 2018;9:108. doi: 10.3389/fphar.2018.00108.", "ArticleIdList": ["10.3389/fphar.2018.00108", "PMC5820334", "29503616"]}, {"Citation": "Stohs S.J., Hartman M.J. Review of the safety and efficacy of Moringa oleifera. Phytother. Res. 2015;29:796\u2013804. doi: 10.1002/ptr.5325.", "ArticleIdList": ["10.1002/ptr.5325", "PMC6680322", "25808883"]}, {"Citation": "Ren Z., Chen S., Guo L. Drug-Induced Liver Toxicity. Humana; New York, NY, USA: 2018. Chapter 8 Use of Liver-Derived Cell Lines for the Study."}, {"Citation": "Vergara-Jimenez M., Almatrafi M.M., Fernandez M.L. Bioactive components in Moringa oleifera leaves protect against chronic disease. Antioxidants. 2017;6:91. doi: 10.3390/antiox6040091.", "ArticleIdList": ["10.3390/antiox6040091", "PMC5745501", "29144438"]}, {"Citation": "Nizio\u0142-\u0141Ukaszewska Z., Furman-Toczek D., Bujak T., Wasilewski T., Hordyjewicz-Baran Z. Moringa oleifera L. Extracts as Bioactive Ingredients That Increase Safety of Body Wash Cosmetics. Dermatol. Res. Pract. 2020;2020:8197902. doi: 10.1155/2020/8197902.", "ArticleIdList": ["10.1155/2020/8197902", "PMC7350073", "32695156"]}, {"Citation": "Sharp P.M., Hahn B.H. The evolution of HIV-1 and the origin of AIDS. Philos. Trans. R. Soc. B Biol. Sci. 2010;365:2487\u20132494. doi: 10.1098/rstb.2010.0031.", "ArticleIdList": ["10.1098/rstb.2010.0031", "PMC2935100", "20643738"]}, {"Citation": "Heeney J.L., Dalgleish A.G., Weiss R.A. Origins of HIV and the evolution of resistance to AIDS. Science. 2006;313:462\u2013466. doi: 10.1126/science.1123016.", "ArticleIdList": ["10.1126/science.1123016", "16873637"]}, {"Citation": "Van Heuverswyn F., Peeters M. The origins of HIV and implications for the global epidemic. Curr. Infect. Dis. Rep. 2007;9:338\u2013346. doi: 10.1007/s11908-007-0052-x.", "ArticleIdList": ["10.1007/s11908-007-0052-x", "17618555"]}, {"Citation": "De Cock K.M., Jaffe H.W., Curran J.W. The evolving epidemiology of HIV/AIDS. Aids. 2012;26:1205\u20131213. doi: 10.1097/QAD.0b013e328354622a.", "ArticleIdList": ["10.1097/QAD.0b013e328354622a", "22706007"]}, {"Citation": "Delpech V., Gahagan J. The global epidemiology of HIV. Medicine. 2009;37:317\u2013320. doi: 10.1016/j.mpmed.2009.04.002.", "ArticleIdList": ["10.1016/j.mpmed.2009.04.002"]}, {"Citation": "Ncube S., Madikizela L.M., Chimuka L., Nindi M.M. Environmental fate and ecotoxicological effects of antiretrovirals: A current global status and future perspectives. Water Res. 2018;145:231\u2013247. doi: 10.1016/j.watres.2018.08.017.", "ArticleIdList": ["10.1016/j.watres.2018.08.017", "30142521"]}, {"Citation": "Nair S., Bayer W., Ploquin M.J.Y., Kassiotis G., Hasenkrug K.J., Dittmer U. Distinct roles of CD4+ T cell subpopulations in retroviral immunity: Lessons from the Friend virus mouse model. Retrovirology. 2011;8:76. doi: 10.1186/1742-4690-8-76.", "ArticleIdList": ["10.1186/1742-4690-8-76", "PMC3193819", "21943070"]}, {"Citation": "Swain S.L., McKinstry K.K., Strutt T.M. Expanding roles for CD4+ T cells in immunity to viruses. Nat. Rev. Immunol. 2012;12:136\u2013148. doi: 10.1038/nri3152.", "ArticleIdList": ["10.1038/nri3152", "PMC3764486", "22266691"]}, {"Citation": "Aavani P., Allen L.J.S. The role of CD4 T cells in immune system activation and viral reproduction in a simple model for HIV infection. Appl. Math. Model. 2019;75:210\u2013222. doi: 10.1016/j.apm.2019.05.028.", "ArticleIdList": ["10.1016/j.apm.2019.05.028"]}, {"Citation": "Kirchhoff F. HIV life cycle: Overview. Encycl. AIDS. 2013:1\u20139. doi: 10.1007/978-1-4614-9610-6_60-1.", "ArticleIdList": ["10.1007/978-1-4614-9610-6_60-1"]}, {"Citation": "Pillay Y., Johnson L. World AIDS day 2020: Reflections on global and South African progress and continuing challenges. S. Afr. J. HIV Med. 2021;22:1205. doi: 10.4102/sajhivmed.v22i1.1205.", "ArticleIdList": ["10.4102/sajhivmed.v22i1.1205", "PMC8008044", "33824738"]}, {"Citation": "Heyer A., Ogunbanjo G.A. Adherence to HIV antiretroviral therapy. Part I: A review of factors that influence adherence. S. Afr. Fam. Pract. 2006;48:5\u20139. doi: 10.1080/20786204.2006.10873433.", "ArticleIdList": ["10.1080/20786204.2006.10873433"]}, {"Citation": "Orton P.M., Sokhela D.G., Nokes K.M., Perazzo J.D., Webel A.R. Factors related to functional exercise capacity amongst people with HIV in Durban, South Africa. Health SA Gesondheid. 2021;26:a1532. doi: 10.4102/hsag.v26i0.1532.", "ArticleIdList": ["10.4102/hsag.v26i0.1532", "PMC8111642", "34007474"]}, {"Citation": "Ramlagan S., Matseke G., Rodriguez V.J., Jones D.L., Peltzer K., Ruiter R.A.C., Sifunda S. Determinants of disclosure and non-disclosure of HIV-positive status, by pregnant women in rural South Africa. Sahara J. 2018;15:155\u2013163. doi: 10.1080/17290376.2018.1529613.", "ArticleIdList": ["10.1080/17290376.2018.1529613", "PMC6197005", "30324859"]}, {"Citation": "Mabaso M., Makola L., Naidoo I., Mlangeni L.L., Jooste S., Simbayi L. HIV prevalence in South Africa through gender and racial lenses: Results from the 2012 population-based national household survey. Int. J. Equity Health. 2019;18:167. doi: 10.1186/s12939-019-1055-6.", "ArticleIdList": ["10.1186/s12939-019-1055-6", "PMC6821038", "31666077"]}, {"Citation": "Loeliger K.B., Niccolai L.M., Mtungwa L.N., Moll A., Shenoi S.V. \u201cI have to push him with a wheelbarrow to the clinic\u201d: Community health workers\u2019 roles, needs, and strategies to improve HIV care in rural South Africa. AIDS Patient Care STDS. 2016;30:385\u2013394. doi: 10.1089/apc.2016.0096.", "ArticleIdList": ["10.1089/apc.2016.0096", "PMC4991585", "27509239"]}, {"Citation": "Bessong P.O., Matume N.D., Tebit D.M. Potential challenges to sustained viral load suppression in the HIV treatment programme in South Africa: A narrative overview. AIDS Res. Ther. 2021;18:1. doi: 10.1186/s12981-020-00324-w.", "ArticleIdList": ["10.1186/s12981-020-00324-w", "PMC7788882", "33407664"]}, {"Citation": "Torti C., Prosperi M., Motta D., Digiambenedetto S., Maggiolo F., Paraninfo G., Ripamonti D., Cologni G., Fabbiani M., Caputo S.L., et al. Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy. Clin. Microbiol. Infect. 2012;18:449\u2013458. doi: 10.1111/j.1469-0691.2011.03650.x.", "ArticleIdList": ["10.1111/j.1469-0691.2011.03650.x", "21919996"]}, {"Citation": "Levi J., Raymond A., Pozniak A., Vernazza P., Kohler P., Hill A. Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades. BMJ Glob. Health. 2016;1:e000010. doi: 10.1136/bmjgh-2015-000010.", "ArticleIdList": ["10.1136/bmjgh-2015-000010", "PMC5321333", "28588933"]}, {"Citation": "AVERT  South Africa 90-90-90 Progress. 2020.  [(accessed on 14 October 2021)].  Available online:  https://www.avert.org/infographics/south-africa-90-90-90-progress."}, {"Citation": "Moses K., Adefisayo O.A., Maryam B., Adeoye A., Oluwatosin A., Abiye K., Kent K., Iyiola F., Tolu A., Homsuk S., et al. Virologic Response among Key Populations Living with HIV following a Switch to Dolutegravir-Based Regimen in Southern Nigeria. Int. J. Virol. AIDS. 2020;7:69. doi: 10.23937/2469-567X/1510069.", "ArticleIdList": ["10.23937/2469-567X/1510069"]}, {"Citation": "Sibanda M., Manimbulu M.N., Naidoo P. Concurrent use of Antiretroviral and African traditional medicines amongst people living with HIV/AIDS (PLWA) in the eThekwini Metropolitan area of KwaZulu Natal. Afr. Health Sci. 2016;16:1118\u20131130. doi: 10.4314/ahs.v16i4.30.", "ArticleIdList": ["10.4314/ahs.v16i4.30", "PMC5398459", "28479905"]}, {"Citation": "Kis O., Robillard K., Chan G.N.Y., Bendayan R. The complexities of antiretroviral drug-drug interactions: Role of ABC and SLC transporters. Trends Pharmacol. Sci. 2010;31:22\u201335. doi: 10.1016/j.tips.2009.10.001.", "ArticleIdList": ["10.1016/j.tips.2009.10.001", "20004485"]}, {"Citation": "Max B., Sherer R. Management of the adverse effects of antiretroviral therapy and medication adherence. Clin. Infect. Dis. 2000;30:S96\u2013S116. doi: 10.1086/313859.", "ArticleIdList": ["10.1086/313859", "10860894"]}, {"Citation": "Ha B., Larsen K.P., Zhang J., Fu Z., Montabana E., Jackson L.N., Chen D.-H., Puglisi E.V. High-resolution view of HIV-1 reverse transcriptase initiation complexes and inhibition by NNRTI drugs. Nat. Commun. 2021;12:2500. doi: 10.1038/s41467-021-22628-9.", "ArticleIdList": ["10.1038/s41467-021-22628-9", "PMC8096811", "33947853"]}, {"Citation": "Temesgen Z., Warnke D., Kasten M.J. Current status of antiretroviral therapy. Expert Opin. Pharmacother. 2006;7:1541\u20131554. doi: 10.1517/14656566.7.12.1541.", "ArticleIdList": ["10.1517/14656566.7.12.1541", "16872258"]}, {"Citation": "Eggleton J., Nagalli S. Highly Active Antiretroviral Therapy (HAART) StatPearls Publishing; Treasure Island, FL, USA: 2022.", "ArticleIdList": ["32119420"]}, {"Citation": "Weber I.T., Wang Y.F., Harrison R.W. HIV protease: Historical perspective and current research. Viruses. 2021;13:839. doi: 10.3390/v13050839.", "ArticleIdList": ["10.3390/v13050839", "PMC8148205", "34066370"]}, {"Citation": "Gabazana Z., Sitole L. Raman-based metabonomics unravels metabolic changes related to a first-line tenofovir-based treatment in a small cohort of South African HIV-infected patients. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2021;248:119256. doi: 10.1016/j.saa.2020.119256.", "ArticleIdList": ["10.1016/j.saa.2020.119256", "33310612"]}, {"Citation": "Kouanfack C., Mpoudi-Etame M., Bassega O., Eymard Duvernay S., Leroy S., Boyer S., Peeters M., Calmy A., Delaporte E. Dolutegravir-Based or Low-Dose Efavirenz\u2013Based Regimen for the Treatment of HIV-1. N. Engl. J. Med. 2019;381:816\u2013826.", "ArticleIdList": ["31339676"]}, {"Citation": "Raffi F., Pozniak A.L., Wainberg M.A. Has the time come to abandon efavirenz for first-line antiretroviral therapy? J. Antimicrob. Chemother. 2014;69:1742\u20131747. doi: 10.1093/jac/dku058.", "ArticleIdList": ["10.1093/jac/dku058", "24603962"]}, {"Citation": "Mendelsohn A.S., Ritchwood T. COVID-19 and Antiretroviral Therapies: South Africa\u2019s Charge Towards 90\u201390\u201390 in the Midst of a Second Pandemic. AIDS Behav. 2020;24:2754\u20132756. doi: 10.1007/s10461-020-02898-y.", "ArticleIdList": ["10.1007/s10461-020-02898-y", "PMC7191543", "32356032"]}, {"Citation": "Desta A., Biru T.T., Kefale A.T. Health related quality of life of people receiving highly active antiretroviral therapy in Southwest Ethiopia. PLoS ONE. 2020;15:e0237013. doi: 10.1371/journal.pone.0237013.", "ArticleIdList": ["10.1371/journal.pone.0237013", "PMC7446831", "32818950"]}, {"Citation": "Anderson P.L., Kiser J.J., Gardner E.M., Rower J.E., Meditz A., Grant R.M. Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection. J. Antimicrob. Chemother. 2011;66:240\u2013250. doi: 10.1093/jac/dkq447.", "ArticleIdList": ["10.1093/jac/dkq447", "PMC3019086", "21118913"]}, {"Citation": "Geboers S., Haenen S., Mols R., Brouwers J., Tack J., Annaert P., Augustijns P. Intestinal behavior of the ester prodrug tenofovir DF in humans. Int. J. Pharm. 2015;485:131\u2013137. doi: 10.1016/j.ijpharm.2015.03.002.", "ArticleIdList": ["10.1016/j.ijpharm.2015.03.002", "25747454"]}, {"Citation": "Wassner C., Bradley N., Lee Y. A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate versus Tenofovir Alafenamide. J. Int. Assoc. Provid. AIDS Care. 2020;19:1\u201310. doi: 10.1177/2325958220919231.", "ArticleIdList": ["10.1177/2325958220919231", "PMC7163232", "32295453"]}, {"Citation": "Cressey T.R., Siriprakaisil O., Kubiak R.W., Klinbuayaem V., Sukrakanchana P., Quame-Amaglo J., Okochi H., Tawon Y., Cressey R., Baeten J.M., et al. Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate. Int. J. Infect. Dis. 2020;97:365\u2013370. doi: 10.1016/j.ijid.2020.06.037.", "ArticleIdList": ["10.1016/j.ijid.2020.06.037", "PMC7392195", "32553717"]}, {"Citation": "James A.M., Ofotokun I., Sheth A., Acosta E.P., King J.R. Tenofovir: Once-daily dosage in the management of HIV infection. Clin. Med. Insights Ther. 2012;4:201\u2013216. doi: 10.4137/CMT.S8316.", "ArticleIdList": ["10.4137/CMT.S8316"]}, {"Citation": "Kearney B.P., Flaherty J.F., Shah J. Tenofovir disoproxil fumarate: Clinical pharmacology and pharmacokinetics. Clin. Pharmacokinet. 2004;43:595\u2013612. doi: 10.2165/00003088-200443090-00003.", "ArticleIdList": ["10.2165/00003088-200443090-00003", "15217303"]}, {"Citation": "Fernandez-Fernandez B., Montoya-Ferrer A., Sanz A.B., Sanchez-Ni\u00f1o M.D., Izquierdo M.C., Poveda J., Sainz-Prestel V., Ortiz-Martin N., Parra-Rodriguez A., Selgas R., et al. Tenofovir nephrotoxicity: 2011 update. AIDS Res. Treat. 2011;2011:354908. doi: 10.1155/2011/354908.", "ArticleIdList": ["10.1155/2011/354908", "PMC3119412", "21716719"]}, {"Citation": "Taylor K., Fritz K., Parmar M. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2023. Lamivudine.", "ArticleIdList": ["32644678"]}, {"Citation": "Else L.J., Jackson A., Puls R., Hill A., Fahey P., Lin E., Amara A., Siccardi M., Watson V., Tjia J., et al. Pharmacokinetics of Lamivudine and Lamivudine-Triphosphate after Administration of 300 Milligrams and 150 Milligrams Once Daily to Healthy Volunteers: Results of the ENCORE 2 Study. Antimicrob. Agents Chemother. 2012;56:1427\u20131433. doi: 10.1128/AAC.05599-11.", "ArticleIdList": ["10.1128/AAC.05599-11", "PMC3294959", "22183172"]}, {"Citation": "Mohan H., Lenis M.G., Laurette E.Y., Tejada O., Sanghvi T., Leung K.Y., Cahill L.S., Sled J.G., Delgado-Olgu\u00edn P., Greene N.D.E., et al. Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels. eBioMedicine. 2021;63:103167. doi: 10.1016/j.ebiom.2020.103167.", "ArticleIdList": ["10.1016/j.ebiom.2020.103167", "PMC7753150", "33341441"]}, {"Citation": "Kandel C.E., Walmsley S.L. Dolutegravir\u2014A review of the pharmacology, efficacy, and safety in the treatment of HIV. Drug Des. Dev. Ther. 2015;9:3547\u20133555. doi: 10.2147/DDDT.S84850.", "ArticleIdList": ["10.2147/DDDT.S84850", "PMC4500604", "26185421"]}, {"Citation": "Castellino S., Moss L., Wagner D., Borland J., Song I., Chen S., Lou Y., Min S.S., Goljer I., Culp A., et al. Metabolism, excretion, and mass balance of the HIV-1 integrase inhibitor dolutegravir in humans. Antimicrob. Agents Chemother. 2013;57:3536\u20133546. doi: 10.1128/AAC.00292-13.", "ArticleIdList": ["10.1128/AAC.00292-13", "PMC3719771", "23669385"]}, {"Citation": "Kaeni M.C. Safety, Tolerability and Adherence of Dtg-Based Regimen among Adult HIV Patients Attending Kenyatta National Hospital. University of Nairobi; Nairobi, Kenya: 2020."}, {"Citation": "Gambo A., Moodley I., Babashani M., Babalola T.K., Gqaleni N. A double-blind, randomized controlled trial to examine the effect of Moringa oleifera leaf powder supplementation on the immune status and anthropometric parameters of adult HIV patients on antiretroviral therapy in a resource-limited setting. PLoS ONE. 2021;16:e0261935. doi: 10.1371/journal.pone.0261935.", "ArticleIdList": ["10.1371/journal.pone.0261935", "PMC8722362", "34972169"]}, {"Citation": "Damtie D., Yismaw G., Woldeyohannes D., Anagaw B. Common opportunistic infections and their CD4 cell correlates among HIV-infected patients attending at antiretroviral therapy clinic of Gondar University Hospital, Northwest Ethiopia. BMC Res. Notes. 2013;6:534. doi: 10.1186/1756-0500-6-534.", "ArticleIdList": ["10.1186/1756-0500-6-534", "PMC3866565", "24330921"]}, {"Citation": "Elias A., Nelson B., Oputiri D., Geoffrey O.B.P. Antiretroviral toxicity and oxidative stress. Am. J. Pharmacol. Toxicol. 2013;8:187\u2013196. doi: 10.3844/ajptsp.2013.187.196.", "ArticleIdList": ["10.3844/ajptsp.2013.187.196"]}, {"Citation": "Paniagua A.C., Amariles P. Hepatotoxicity by Drugs, Pharmacokinetics and Adverse Effects of Drugs\u2014Mechanisms and Risks Factors. IntechOpen; London, UK: 2018."}, {"Citation": "Singh A., Bhat T.K., Sharma O.P. Clinical biochemistry of hepatotoxicity. J. Clinic. Toxicol. S. 2011;4:2161-0495."}, {"Citation": "Chhatwani C., Purohit J., Vakil A., Khunt S. Tenofovir Induced Severe Lactic Acidosis and Hepatitis. Natl. J. Med. Res. 2016;6:288\u2013289."}, {"Citation": "Smith R.L., de Boer R., Brul S., Budovskaya Y., van der Spek H. Premature and accelerated aging: HIV or HAART? Front. Genet. 2013;3:328. doi: 10.3389/fgene.2012.00328.", "ArticleIdList": ["10.3389/fgene.2012.00328", "PMC3556597", "23372574"]}, {"Citation": "Akay C., Cooper M., Odeleye A., Jensen B.K., White M.G., Vassoler F., Gannon P.J., Mankowski J., Dorsey J.L., Buch A.M., et al. Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system. J. Neurovirol. 2014;20:39\u201353. doi: 10.1007/s13365-013-0227-1.", "ArticleIdList": ["10.1007/s13365-013-0227-1", "PMC3928514", "24420448"]}, {"Citation": "Warnke D., Barreto J., Temesgen Z. Therapeutic review: Antiretroviral drugs. J. Clin. Pharmacol. 2007;47:1570\u20131579. doi: 10.1177/0091270007308034.", "ArticleIdList": ["10.1177/0091270007308034", "18048575"]}, {"Citation": "Kline E.R., Bassit L., Hernandez-Santiago B.I., Detorio M.A., Liang B., Kleinhenz D.J., Walp E.R., Dikalov S., Jones D.P., Schinazi R.F., et al. Long-term exposure to AZT, but not d4T, increases endothelial cell oxidative stress and mitochondrial dysfunction. Cardiovasc. Toxicol. 2009;9:1\u201312. doi: 10.1007/s12012-008-9029-8.", "ArticleIdList": ["10.1007/s12012-008-9029-8", "PMC2714048", "19067249"]}, {"Citation": "\u010eura\u010dkov\u00e1 Z. Some current insights into oxidative stress.  [(accessed on 15 February 2021)];Physiol. Res. 2010 8408:459\u2013469. doi: 10.33549/physiolres.931844. Available online:  http://www.biomed.cas.cz/physiolres/pdf/59/59_459.pdf.", "ArticleIdList": ["10.33549/physiolres.931844", "19929132"]}, {"Citation": "de Andrade J\u00fanior D.R., Souza R.B., Santos S.A. Oxygen free radicals and pulmonary disease. J. Bras. Pneumol. J. Bras. Pneumol. 2005;31:60\u201368."}, {"Citation": "Phaniendra A., Jestadi D.B., Periyasamy L. Free Radicals: Properties, Sources, Targets, and Their Implication in Various Diseases. Indian J. Clin. Biochem. 2015;30:11\u201326. doi: 10.1007/s12291-014-0446-0.", "ArticleIdList": ["10.1007/s12291-014-0446-0", "PMC4310837", "25646037"]}, {"Citation": "Lambert A.J., Brand M.D. Reactive oxygen species production by mitochondria. Methods Mol. Biol. 2009;554:165\u2013181.", "ArticleIdList": ["19513674"]}, {"Citation": "Pham-Huy L.A., He H., Pham-Huy C. Free radicals, antioxidants in disease and health. Int. J. Biomed. Sci. 2008;4:89\u201396.", "ArticleIdList": ["PMC3614697", "23675073"]}, {"Citation": "Andr\u00e9s Juan C., Manuel P\u00e9rez de la Lastra J., Plou F.J., P\u00e9rez-Lebe\u00f1a E., Reinbothe S. Molecular Sciences The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies. Int. J. Mol. Sci. 2021;22:4642. doi: 10.3390/ijms22094642.", "ArticleIdList": ["10.3390/ijms22094642", "PMC8125527", "33924958"]}, {"Citation": "Gupta S.D. Chapter 11 Role of Free Radicals and Antioxidants in In Vitro. 2010.  [(accessed on 16 February 2021)].  Available online:  https://www.researchgate.net/profile/Snehasish-Dutta-Gupta/publication/260227296_Role_of_free_radicals_and_antioxidants_in_in_vitro_morphogenesis/links/0deec53832658c2751000000/Role-of-free-radicals-and-antioxidants-in-in-vitro-morphogenesis.pdf."}, {"Citation": "Doshi S.B., Khullar K., Sharma R.K., Agarwal A. Role of reactive nitrogen species in male infertility. Reprod. Biol. Endocrinol. 2012;10:109. doi: 10.1186/1477-7827-10-109.", "ArticleIdList": ["10.1186/1477-7827-10-109", "PMC3558381", "23241221"]}, {"Citation": "Mart\u00ednez C.M., Andriantsitohaina R. Reactive Nitrogen Species: Molecular Mechanisms and Potential Significance in Health and Disease. Antioxid. Redox Signal. 2009;11:669\u2013702. doi: 10.1089/ars.2007.1993.", "ArticleIdList": ["10.1089/ars.2007.1993", "19014277"]}, {"Citation": "Su L.J., Zhang J.H., Gomez H., Murugan R., Hong X., Xu D., Jiang F., Peng Z.Y. Review Article Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis. Oxidative Med. Cell. Longev. 2019;2019:5080843.", "ArticleIdList": ["PMC6815535", "31737171"]}, {"Citation": "Mas-Bargues C., Escriv\u00e1 C., Dromant M., Borr\u00e1s C., Vi\u00f1a J. Lipid peroxidation as measured by chromatographic determination of malondialdehyde. Human plasma reference values in health and disease. Arch. Biochem. Biophys. 2021;709:108941. doi: 10.1016/j.abb.2021.108941.", "ArticleIdList": ["10.1016/j.abb.2021.108941", "34097903"]}, {"Citation": "Barrera G., Pizzimenti S., Daga M., Dianzani C., Arcaro A., Cetrangolo G.P., Giordano G., Cucci M.A., Graf M., Gentile F. Lipid peroxidation-derived aldehydes, 4-hydroxynonenal and malondialdehyde in aging-related disorders. Antioxidants. 2018;7:102. doi: 10.3390/antiox7080102.", "ArticleIdList": ["10.3390/antiox7080102", "PMC6115986", "30061536"]}, {"Citation": "Ayala A., Mu\u00f1oz M.F., Arg\u00fcelles S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell. Longev. 2014;2014:360438. doi: 10.1155/2014/360438.", "ArticleIdList": ["10.1155/2014/360438", "PMC4066722", "24999379"]}, {"Citation": "Alkadi H. A Review on Free Radicals and Antioxidants. Infect. Disord. Drug Targets. 2018;20:16\u201326.", "ArticleIdList": ["29952268"]}, {"Citation": "Henriksen E.J. Bioactive Food as Dietary Interventions for Diabetes. Elsevier; Amsterdam, The Netherlands: 2019. Role of Oxidative Stress in the Pathogenesis of Insulin Resistance and Type 2 Diabetes; pp. 3\u201317."}, {"Citation": "Kuciel-Lewandowska J.M., Pawlik-Sobecka L., P\u0142aczkowska S., Kokot I., Paprocka-Borowicz M. The assessment of the integrated antioxidant system of the body and the phenomenon of spa reaction in the course of radon therapy: A pilot study. Adv. Clin. Exp. Med. 2018;27:1341\u20131346.", "ArticleIdList": ["30085431"]}, {"Citation": "Matough F.A., Budin S.B., Hamid Z.A., Alwahaibi N., Mohamed J. The role of oxidative stress and antioxidants in diabetic complications. Sultan. Qaboos Univ. Med. J. 2012;12:556\u2013569. doi: 10.12816/0003082.", "ArticleIdList": ["10.12816/0003082", "PMC3286717", "22375253"]}, {"Citation": "Bouayed J., Bohn T. Exogenous antioxidants\u2014Double-edged swords in cellular redox state: Health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid. Med. Cell. Longev. 2010;3:228\u2013237. doi: 10.4161/oxim.3.4.12858.", "ArticleIdList": ["10.4161/oxim.3.4.12858", "PMC2952083", "20972369"]}, {"Citation": "L\u00fc J.M., Lin P.H., Yao Q., Chen C. Chemical and molecular mechanisms of antioxidants: Experimental approaches and model systems. J. Cell Mol. Med. 2010;14:840\u2013860. doi: 10.1111/j.1582-4934.2009.00897.x.", "ArticleIdList": ["10.1111/j.1582-4934.2009.00897.x", "PMC2927345", "19754673"]}, {"Citation": "Ighodaro O.M., Akinloye O.A. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alex. J. Med. 2018;54:287\u2013293. doi: 10.1016/j.ajme.2017.09.001.", "ArticleIdList": ["10.1016/j.ajme.2017.09.001"]}, {"Citation": "de Vries H.E., Witte M., Hondius D., Rozemuller A.J.M., Drukarch B., Hoozemans J., van Horssen J. Nrf2-induced antioxidant protection: A promising target to counteract ROS-mediated damage in neurodegenerative disease? Free. Radic. Biol. Med. 2008;4:1375\u20131383. doi: 10.1016/j.freeradbiomed.2008.09.001.", "ArticleIdList": ["10.1016/j.freeradbiomed.2008.09.001", "18824091"]}, {"Citation": "Younus H. Therapeutic potentials of superoxide dismutase. Int. J. Health Sci.\n2018, 12, 88\u201393.  [(accessed on 2 March 2021)]; Available online:  http://www.ncbi.nlm.nih.gov/pubmed/29896077%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5969776.", "ArticleIdList": ["PMC5969776", "29896077"]}, {"Citation": "Pourvali K., Abbasi M., Mottaghi A. Role of superoxide dismutase 2 gene Ala16Val polymorphism and total antioxidant capacity in diabetes and its complications. Avicenna J. Med. Biotechnol. 2016;8:48\u201356.", "ArticleIdList": ["PMC4842242", "27141263"]}, {"Citation": "Glorieux C., Zamocky M., Sandoval J.M., Verrax J., Calderon P.B. Regulation of catalase expression in healthy and cancerous cells. Free. Radic. Biol. Med. 2015;87:84\u201397. doi: 10.1016/j.freeradbiomed.2015.06.017.", "ArticleIdList": ["10.1016/j.freeradbiomed.2015.06.017", "26117330"]}, {"Citation": "Grigoras A.G. Catalase immobilization\u2014A review. Biochem. Eng. J. 2017;117:1\u201320. doi: 10.1016/j.bej.2016.10.021.", "ArticleIdList": ["10.1016/j.bej.2016.10.021"]}, {"Citation": "Sies H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative eustress. Redox Biol. 2017;11:613\u2013619. doi: 10.1016/j.redox.2016.12.035.", "ArticleIdList": ["10.1016/j.redox.2016.12.035", "PMC5256672", "28110218"]}, {"Citation": "Noctor G., Queval G., Mhamdi A., Chaouch S., Foyer C.H. Glutathione. Arab. Book. 2011;9:e0142. doi: 10.1199/tab.0142.", "ArticleIdList": ["10.1199/tab.0142", "PMC3267239", "22303267"]}, {"Citation": "Wu G., Fang Y.Z., Yang S., Lupton J.R., Turner N.D. Glutathione Metabolism and Its Implications for Health. J. Nutr. 2004;134:489\u2013492. doi: 10.1093/jn/134.3.489.", "ArticleIdList": ["10.1093/jn/134.3.489", "14988435"]}, {"Citation": "Franklin C.C., Backos D.S., Mohar I., White C.C., Forman H.J., Kavanagh T.J. Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol. Asp. Med. 2009;30:86\u201398. doi: 10.1016/j.mam.2008.08.009.", "ArticleIdList": ["10.1016/j.mam.2008.08.009", "PMC2714364", "18812186"]}, {"Citation": "Krejsa C.M., Franklin C.C., White C.C., Ledbetter J.A., Schieven G.L., Kavanagh T.J. Rapid activation of glutamate cysteine ligase following oxidative stress. J. Biol. Chem. 2010;285:16116\u201316124. doi: 10.1074/jbc.M110.116210.", "ArticleIdList": ["10.1074/jbc.M110.116210", "PMC2871480", "20332089"]}, {"Citation": "Koide S.I., Kugiyama K., Sugiyama S., Nakamura S.I., Fukushima H., Honda O., Yoshimura M., Ogawa H. Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction. J. Am. Coll. Cardiol. 2003;41:539\u2013545. doi: 10.1016/S0735-1097(02)02866-8.", "ArticleIdList": ["10.1016/S0735-1097(02)02866-8", "12598062"]}, {"Citation": "Lu S.C. Glutathione synthesis. Biochim. Biophys. Acta Gen. Subj. 2013;1830:3143\u20133153. doi: 10.1016/j.bbagen.2012.09.008.", "ArticleIdList": ["10.1016/j.bbagen.2012.09.008", "PMC3549305", "22995213"]}, {"Citation": "Behnisch-Cornwell S., Wolff L., Bednarski P.J. The effect of glutathione peroxidase-1 knockout on anticancer drug sensitivities and reactive oxygen species in haploid HAP-1 cells. Antioxidants. 2020;9:1300. doi: 10.3390/antiox9121300.", "ArticleIdList": ["10.3390/antiox9121300", "PMC7766971", "33353055"]}, {"Citation": "Sar\u0131kaya E., Do\u011fan S.  Glutathione Peroxidase in Health and Diseases. Volume 49. IntechOpen; London, UK: 2020.  [(accessed on 3 March 2021)].  Available online:  https://www.researchgate.net/publication/339093247_Glutathione_Peroxidase_in_Health_and_Diseases."}, {"Citation": "Guo K., Ge J., Zhang C., Lv M.W., Zhang Q., Talukder M., Li J.-L. Cadmium induced cardiac inflammation in chicken (Gallus gallus) via modulating cytochrome P450 systems and Nrf2 mediated antioxidant defense. Chemosphere. 2020;249:125858. doi: 10.1016/j.chemosphere.2020.125858.", "ArticleIdList": ["10.1016/j.chemosphere.2020.125858", "32062552"]}, {"Citation": "Nagiah S., Phulukdaree A., Chuturgoon A. Mitochondrial and Oxidative Stress Response in HepG2 Cells Following Acute and Prolonged Exposure to Antiretroviral Drugs. J. Cell Biochem. 2015;116:1939\u20131946. doi: 10.1002/jcb.25149.", "ArticleIdList": ["10.1002/jcb.25149", "25740676"]}, {"Citation": "Holmstr\u00f6m K.M., Kostov R.V., Dinkova-Kostova A.T. The multifaceted role of Nrf2 in mitochondrial function. Curr. Opin. Toxicol. 2016;2:80\u201391. doi: 10.1016/j.cotox.2016.10.002.", "ArticleIdList": ["10.1016/j.cotox.2016.10.002", "PMC5193490", "28066829"]}, {"Citation": "Lee D.H., Gold R., Linker R.A. Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: Therapeutic modulation via fumaric acid esters. Int. J. Mol. Sci. 2012;13:11783\u201311803. doi: 10.3390/ijms130911783.", "ArticleIdList": ["10.3390/ijms130911783", "PMC3472775", "23109883"]}, {"Citation": "Sobiecki J.F. The Intersection of Culture and Science in South African Traditional Medicine. Indo-Pac. J. Phenomenol. 2014;14:1\u201310. doi: 10.2989/IPJP.2014.14.1.6.1238.", "ArticleIdList": ["10.2989/IPJP.2014.14.1.6.1238"]}, {"Citation": "Street R.A., Stirk W.A., Van Staden J. South African traditional medicinal plant trade-Challenges in regulating quality, safety and efficacy. J. Ethnopharmacol. 2008;119:705\u2013710. doi: 10.1016/j.jep.2008.06.019.", "ArticleIdList": ["10.1016/j.jep.2008.06.019", "18638533"]}, {"Citation": "Street R.A., Prinsloo G. Commercially important medicinal plants of South Africa: A review. J. Chem. 2013;2013:205048. doi: 10.1155/2013/205048.", "ArticleIdList": ["10.1155/2013/205048"]}, {"Citation": "Altemimi A., Lakhssassi N., Baharlouei A., Watson D.G., Lightfoot D.A. Phytochemicals: Extraction, isolation, and identification of bioactive compounds from plant extracts. Plants. 2017;6:42. doi: 10.3390/plants6040042.", "ArticleIdList": ["10.3390/plants6040042", "PMC5750618", "28937585"]}, {"Citation": "Peltzer K., Preez N.F.d., Ramlagan S., Fomundam H., Anderson J., Chanetsa L. Antiretrovirals and the Use of Traditional, Complementary and Alternative Medicine by HIV Patients in Kwazulu-Natal, South Africa: A longitudinal study. Afr. J. Tradit. Complement. Altern. Med. 2011;8:337\u2013345. doi: 10.4314/ajtcam.v8i4.1.", "ArticleIdList": ["10.4314/ajtcam.v8i4.1", "PMC3218455", "22654209"]}, {"Citation": "Mills E., Cooper C., Seely D., Kanfer I. African herbal medicines in the treatment of HIV: Hypoxis and Sutherlandia. An overview of evidence and pharmacology. Nutr. J. 2005;4:19. doi: 10.1186/1475-2891-4-19.", "ArticleIdList": ["10.1186/1475-2891-4-19", "PMC1156943", "15927053"]}, {"Citation": "Dukhi N., Taylor M. A focus on four popular \u201cfunctional foods\u201d as part of a strategy to combat metabolic disease through the increased consumption of fruits and vegetables. Curr. Res. Nutr. Food Sci. 2018;6:294\u2013306. doi: 10.12944/CRNFSJ.6.2.05.", "ArticleIdList": ["10.12944/CRNFSJ.6.2.05"]}, {"Citation": "Luhlaza-ISS  Growing and Agro-Processing of Moringa Oleifera with Commercial Potential in South Africa; Industrial Development Corporation of South Africa (IDC); 2006; Volume 43, pp. 1\u2013108.  [(accessed on 23 October 2021)].  Available online:  https://drive.google.com/file/d/1iZfoUMXG_2FZIucWnWxos0FdPnak_b1S/view."}, {"Citation": "Monera-Penduka T.G., Maponga C.C., Wolfe A.R., Wiesner L., Morse G.D., Nhachi C.F.B. Effect of Moringa oleifera Lam. leaf powder on the pharmacokinetics of nevirapine in HIV-infected adults: A one sequence cross-over study. AIDS Res. Ther. 2017;14:12. doi: 10.1186/s12981-017-0140-4.", "ArticleIdList": ["10.1186/s12981-017-0140-4", "PMC5348890", "28293270"]}, {"Citation": "Coppin J. Master\u2019s Thesis. The State University of New Jersey; New Brunswick, NJ, USA: 2008. A Study of the Nutritional and Medicinal Values of Moringa oleifera Leaves from Sub-Saharan Africa: Ghana, Rwanda, Senegal and Zambia."}, {"Citation": "Razis A.F.A., Ibrahim M.D., Kntayya S.B. Health benefits of Moringa oleifera. Asian Pac. J. Cancer Prev. 2014;15:8571\u20138576. doi: 10.7314/APJCP.2014.15.20.8571.", "ArticleIdList": ["10.7314/APJCP.2014.15.20.8571", "25374169"]}, {"Citation": "Patwardhan B., Warude D., Pushpangadan P., Bhatt N. Ayurveda and traditional Chinese medicine: A comparative overview. Evid. Based Complement. Altern. Med. 2005;2:465\u2013473. doi: 10.1093/ecam/neh140.", "ArticleIdList": ["10.1093/ecam/neh140", "PMC1297513", "16322803"]}, {"Citation": "Mukherjee A., Banerjee M., Mandal V., Shukla A.C., Mandal S.C. Modernization of Ayurveda: A brief overview of Indian initiatives. Nat. Prod. Commun. 2014;9:287\u2013290. doi: 10.1177/1934578X1400900239.", "ArticleIdList": ["10.1177/1934578X1400900239", "24689312"]}, {"Citation": "Leone A., Spada A., Battezzati A., Schiraldi A., Aristil J., Bertoli S. Cultivation, Genetic, Ethnopharmacology, Phytochemistry and Pharmacology of Moringa oleifera Leaves: An Overview. Int. J. Mol. Sci. 2015;16:12791\u201312835. doi: 10.3390/ijms160612791.", "ArticleIdList": ["10.3390/ijms160612791", "PMC4490473", "26057747"]}, {"Citation": "Tomar M., Subha K., Reetu D., Bhargavi H.A. Moringa oleifera: A health food for animal and human consumption. Food Sci. Rep. 2020;1:11\u201314."}, {"Citation": "Devkota S., Bhusal K.K. Moringa oleifera: A miracle multipurpose tree for agroforestry and climate change mitigation from the Himalayas\u2014A review. Cogent Food Agric. 2020;6:1805951. doi: 10.1080/23311932.2020.1805951.", "ArticleIdList": ["10.1080/23311932.2020.1805951"]}, {"Citation": "Mashamaite C.V., Pieterse P.J., Mothapo P.N., Phiri E.E. Moringa oleifera in South Africa: A review on its production, growing conditions and consumption as a food source. S. Afr. J. Sci. 2021;117:1\u20137. doi: 10.17159/sajs.2021/8689.", "ArticleIdList": ["10.17159/sajs.2021/8689", "0"]}, {"Citation": "Tiloke C. Ph.D. Thesis. University of KwaZulu-Natal; Durban, South Africa: 2015. The Antiproliferative and Apoptosis Inducing Effects of Moringa oleifera Aqueous Leaf Extract and Its Synthesised Gold Nanoparticles-Modulation of Oncogenes and Tumour Supppressor Genes in Human Cancer Cell Lines."}, {"Citation": "Paikra B.K., Dhongade H.K.J., Gidwani B. Phytochemistry and pharmacology of Moringa oleifera Lam. J. Pharmacopunct. 2017;20:194\u2013200.", "ArticleIdList": ["PMC5633671", "30087795"]}, {"Citation": "Trigo C., Castell\u00f3 M.L., Ortol\u00e1 M.D., Garc\u00eda-Mares F.J., Soriano M.D. Moringa oleifera: An Unknown Crop in Developed Countries with Great Potential for Industry and Adapted to Climate Change. Foods. 2021;10:31. doi: 10.3390/foods10010031.", "ArticleIdList": ["10.3390/foods10010031", "PMC7824577", "33374455"]}, {"Citation": "Pe\u00f1alver R., Mart\u00ednez-Zamora L., Lorenzo J.M., Ros G., Nieto G. Nutritional and Antioxidant Properties of Moringa oleifera Leaves in Functional Foods. Foods. 2022;11:1107. doi: 10.3390/foods11081107.", "ArticleIdList": ["10.3390/foods11081107", "PMC9030530", "35454694"]}, {"Citation": "Kashyap P., Kumar S., Riar C.S., Jindal N., Baniwal P., Guin\u00e9 R.P.F., Correia P.M.R., Mehra R., Kumar H. Recent Advances in Drumstick (Moringa oleifera) Leaves Bioactive Compounds: Composition, Health Benefits, Bioaccessibility, and Dietary Applications. Antioxidants. 2022;11:402. doi: 10.3390/antiox11020402.", "ArticleIdList": ["10.3390/antiox11020402", "PMC8869219", "35204283"]}, {"Citation": "Safe S., Jayaraman A., Chapkin R.S., Howard M., Mohankumar K., Shrestha R. Flavonoids: Structure\u2013function and mechanisms of action and opportunities for drug development. Toxicol. Res. 2021;37:147\u2013162. doi: 10.1007/s43188-020-00080-z.", "ArticleIdList": ["10.1007/s43188-020-00080-z", "PMC8007671", "33868973"]}, {"Citation": "Lin M., Zhang J., Chen X. Bioactive flavonoids in Moringa oleifera and their health-promoting properties. J. Funct. Foods. 2018;47:469\u2013479. doi: 10.1016/j.jff.2018.06.011.", "ArticleIdList": ["10.1016/j.jff.2018.06.011"]}, {"Citation": "Panche A.N., Diwan A.D., Chandra S.R. Flavonoids: An overview. J. Nutr. Sci. 2016;5:E47. doi: 10.1017/jns.2016.41.", "ArticleIdList": ["10.1017/jns.2016.41", "PMC5465813", "28620474"]}, {"Citation": "de la Rosa L.A., Moreno-Escamilla J.O., Rodrigo-Garc\u00eda J., Alvarez-Parrilla E. Postharvest Physiology and Biochemistry of Fruits and Vegetables. Elsevier; Amsterdam, The Netherlands: 2018. Phenolic compounds; pp. 253\u2013271."}, {"Citation": "Chen J., Yang J., Ma L., Li J., Shahzad N., Kim C.K. Structure-antioxidant activity relationship of methoxy, phenolic hydroxyl, and carboxylic acid groups of phenolic acids. Sci. Rep. 2020;10:2611. doi: 10.1038/s41598-020-59451-z.", "ArticleIdList": ["10.1038/s41598-020-59451-z", "PMC7018807", "32054964"]}, {"Citation": "Rungratanawanich W., Memo M., Uberti D. Redox homeostasis and natural dietary compounds: Focusing on antioxidants of rice (Oryza sativa L.) Nutrients. 2018;10:1605. doi: 10.3390/nu10111605.", "ArticleIdList": ["10.3390/nu10111605", "PMC6265930", "30388764"]}, {"Citation": "Maoka T. Carotenoids as natural functional pigments. J. Nat. Med. 2020;74:1\u201316. doi: 10.1007/s11418-019-01364-x.", "ArticleIdList": ["10.1007/s11418-019-01364-x", "PMC6949322", "31588965"]}, {"Citation": "Mezzomo N., Ferreira S.R.S. Carotenoids functionality, sources, and processing by supercritical technology: A review. J. Chem. 2016;2016:3164312. doi: 10.1155/2016/3164312.", "ArticleIdList": ["10.1155/2016/3164312"]}, {"Citation": "Fiedor J., Burda K. Potential role of carotenoids as antioxidants in human health and disease. Nutrients. 2014;6:466\u2013488. doi: 10.3390/nu6020466.", "ArticleIdList": ["10.3390/nu6020466", "PMC3942711", "24473231"]}, {"Citation": "Sandmann G. Antioxidant protection from UV-and light-stress related to carotenoid structures. Antioxidants. 2019;8:219. doi: 10.3390/antiox8070219.", "ArticleIdList": ["10.3390/antiox8070219", "PMC6680902", "31336715"]}, {"Citation": "Zhang Y.J., Gan R.Y., Li S., Zhou Y., Li A.N., Xu D.P., Li H.B. Antioxidant phytochemicals for the prevention and treatment of chronic diseases. Molecules. 2015;20:21138\u201321156. doi: 10.3390/molecules201219753.", "ArticleIdList": ["10.3390/molecules201219753", "PMC6331972", "26633317"]}, {"Citation": "Gopalakrishnan L., Doriya K., Kumar D.S. Moringa oleifera: A review on nutritive importance and its medicinal application. Food Sci. Hum. Wellness. 2016;5:49\u201356. doi: 10.1016/j.fshw.2016.04.001.", "ArticleIdList": ["10.1016/j.fshw.2016.04.001"]}, {"Citation": "Brilhante R.S.N., Sales J.A., Pereira V.S., Castelo-Branco D.d.S.C.M., Cordeiro R.d.A., de Souza Sampaio C.M., Paiva M.d.A.N., dos Santos J.B.F., Sidrim J.J.C., Rocha M.F.G. Research advances on the multiple uses of Moringa oleifera: A sustainable alternative for socially neglected population. Asian Pac. J. Trop Med. 2017;10:621\u2013630. doi: 10.1016/j.apjtm.2017.07.002.", "ArticleIdList": ["10.1016/j.apjtm.2017.07.002", "28870337"]}, {"Citation": "Harjum\u00e4ki R., Nugroho R.W.N., Zhang X., Lou Y.R., Yliperttula M., Valle-Delgado J.J., \u00d6sterberg M. Author Correction: Quantified forces between HepG2 hepatocarcinoma and WA07 pluripotent stem cells with natural biomaterials correlate with in vitro cell behavior. Sci. Rep. 2019;9:7354. doi: 10.1038/s41598-019-43669-7. Erratum in Sci. Rep. 2020, 10, 8803.", "ArticleIdList": ["10.1038/s41598-019-43669-7", "PMC6517585", "31089156"]}, {"Citation": "Donato M.T., Tolosa L., G\u00f3mez-Lech\u00f3n M.J. Protocols in In Vitro Hepatocyte Research. Humana Press; New York, NY, USA: 2015. Culture and Functional Characterization of Human Hepatoma HepG2 Cells; pp. 77\u201393.", "ArticleIdList": ["26272135"]}, {"Citation": "Pinti M., Troiano L., Ferraresi R., Dobrucki J., Cossarizza A. Hepatoma HepG2 cells as a model for in vitro studies on mitochondrial toxicity of antiviral drugs: Which correlation with the patient? J. Biol. Regul. Homeost. Agents. 2003;17:166\u2013171.", "ArticleIdList": ["14518717"]}, {"Citation": "Paemanee A., Sornjai W., Kittisenachai S. Nevirapine induced mitochondrial dysfunction in HepG2 cells. Sci. Rep. 2017;7:9194. doi: 10.1038/s41598-017-09321-y.", "ArticleIdList": ["10.1038/s41598-017-09321-y", "PMC5569014", "28835669"]}, {"Citation": "Shamsabadi A.A. Master\u2019s Thesis. University of Brighton; Brighton, UK: 2014. Investigation into the Hepatotoxic Effects of Highly Active Anti-Retroviral Therapy (HAART) Medications."}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "7", "Day": "4"}, {"Year": "2023", "Month": "8", "Day": "20"}, {"Year": "2023", "Month": "9", "Day": "7"}, {"Year": "2023", "Month": "9", "Day": "28", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "9", "Day": "28", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "9", "Day": "28", "Hour": "1", "Minute": "39"}, {"Year": "2023", "Month": "9", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["37765399", "PMC10537654", "10.3390/plants12183235", "plants12183235"]}}], "PubmedBookArticle": []}